Although 61% surveyed agree that flu vaccination is the best preventive measure against flu-related deaths and hospitalizations, 44% of US adults are either unsure or do not plan to get the vaccination.
As the United States and the rest of the world grudgingly accepts that COVID-19 will be with us from here on out, another infection that hits us in waves seems not to be getting the attention it deserves: influenza.
Just over half of US adults are planning to get vaccinated for influenza despite urging by health officials concerned with potential influenza resurgence during the COVID-19 pandemic, according to a new survey by the National Foundation for Infectious Diseases (NFID).
The survey, conducted August 12-16, 2021, found that although 61% agree that flu vaccination is the best preventive measure against flu-related deaths and hospitalizations, 44% of US adults are either unsure or do not plan to get the vaccination. The NFID-sponsored survey was conducted by NORC, a social research institution at the University of Chicago.
In a news conference announcing the survey findings, Rochelle Walensky, MD, MPH, director, Centers for Disease Control and Prevention (CDC), emphasized the importance of the influenza vaccination.
“While we do not know what the activity will be like this fall, I urge everyone age 6 months and older to get vaccinated. If you are unsure about getting a flu vaccine, please take the time to get the information you need to make the right choice for your health and to get vaccinated,” Walensky urged. “The COVID-19 pandemic is not over, and the risk of both flu and COVID-19 circulating could put additional strain on hospitals and frontline health care professionals.”
An NFID statement indicated that the survey was conducted to obtain a better understanding of the beliefs about flu and pneumococcal disease, as well as attitudes and practices around vaccination, and how these may be affected by the COVID-19 pandemic. The survey included 1126 complete responses, with 1064 via the web and 62 via telephone, from US adults age 18 years and older representing all US states and the District of Columbia.
Among those not planning to get vaccinated, the most frequent reasons were: do not think vaccine works very well (39%); never get the flu (36%); concern about potential side effects (25%); don't think flu is serious illness (20%); concern about getting flu from vaccine (19%).
The prospect of low vaccination rates poses particular hazard to those at highest risk for flu-related complications, according to the health experts at the news conference. They noted that nearly 1 in 4 (23%) adults who are at high risk had indicated that they were not planning to get vaccinated this season, not only leaving them vulnerable, but increasing likelihood of transmission.
“Amid the ongoing pandemic, we remain extremely concerned about patients with chronic health conditions who are at higher risk for pneumococcal disease and complications from flu and COVID-19,” indicated Cedric Rutland, MD, West Coast Lung, Newport Beach, CA.
Patricia Stinchfield, RN, MS, NFID president-elect highlighted the youngest, vulnerable population."Children age 6 years and younger are at higher risk of serious flu-related illness, and we need to ensure our children are protected before flu starts spreading in schools and communities. Flu vaccines can be life saving for children," she declared.
Laura Riley, MD, Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, noted that the current 55% vaccination coverage of pregnant women was similar to the prior season. “Nearly half of pregnant women and their infants remain unprotected against flu,” Riley said. “All pregnant women should get a flu vaccine to protect themselves and their newborn babies from severe complications.”
Other findings from the survey include:
“Survey findings highlight the importance of raising awareness and addressing misconceptions about flu, pneumococal disease, and COVID-19 vaccines, and the importance of health care professionals strongly recommending vaccines for their patients,” the NFID indicated in the press release.
This article first appeared inContagion®.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.